| Site-specifically labeled immunoconjugates for molecular imaging—part 1: cysteine residues and glycans P Adumeau, SK Sharma, C Brent, BM Zeglis Molecular Imaging and Biology 18, 1-17, 2016 | 117 | 2016 |
| Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity A Chow, S Schad, MD Green, MD Hellmann, V Allaj, N Ceglia, G Zago, ... Cancer Cell 39 (7), 973-988. e9, 2021 | 110 | 2021 |
| Synthesis and evaluation of 1, 5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors BJ Al-Hourani, SK Sharma, JY Mane, J Tuszynski, V Baracos, T Kniess, ... Bioorganic & medicinal chemistry letters 21 (6), 1823-1826, 2011 | 107 | 2011 |
| Noninvasive interrogation of DLL3 expression in metastatic small cell lung cancer SK Sharma, J Pourat, D Abdel-Atti, SD Carlin, A Piersigilli, AJ Bankovich, ... Cancer research 77 (14), 3931-3941, 2017 | 103 | 2017 |
| Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy PMR Pereira, SK Sharma, LM Carter, KJ Edwards, J Pourat, A Ragupathi, ... Nature communications 9 (1), 5137, 2018 | 98 | 2018 |
| Fc-mediated anomalous biodistribution of therapeutic antibodies in immunodeficient mouse models SK Sharma, A Chow, S Monette, D Vivier, J Pourat, KJ Edwards, ... Cancer research 78 (7), 1820-1832, 2018 | 82 | 2018 |
| Site-specifically labeled immunoconjugates for molecular imaging—part 2: peptide tags and unnatural amino acids P Adumeau, SK Sharma, C Brent, BM Zeglis Molecular Imaging and Biology 18, 153-165, 2016 | 73 | 2016 |
| Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors BJ Al-Hourani, SK Sharma, M Suresh, F Wuest Bioorganic & medicinal chemistry letters 22 (6), 2235-2238, 2012 | 53 | 2012 |
| A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals SK Sharma, SK Lyashchenko, HA Park, N Pillarsetty, Y Roux, J Wu, ... Nuclear medicine and biology 71, 32-38, 2019 | 52 | 2019 |
| Site-specifically labeled antibody–drug conjugate for simultaneous therapy and immunoPET P Adumeau, D Vivier, SK Sharma, J Wang, T Zhang, A Chen, BJ Agnew, ... Molecular pharmaceutics 15 (3), 892-898, 2018 | 48 | 2018 |
| Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer MR McDevitt, DLJ Thorek, T Hashimoto, T Gondo, DR Veach, SK Sharma, ... Nature communications 9 (1), 1629, 2018 | 45 | 2018 |
| Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging D Vivier, SK Sharma, BM Zeglis Journal of Labelled Compounds and Radiopharmaceuticals 61 (9), 672-692, 2018 | 43 | 2018 |
| Preclinical 89Zr immuno-PET of high-grade serous ovarian cancer and lymph node metastasis SK Sharma, KK Sevak, S Monette, SD Carlin, JC Knight, FR Wuest, ... Journal of Nuclear Medicine 57 (5), 771-776, 2016 | 42 | 2016 |
| The impact of FcγRI binding on immuno-PET D Vivier, SK Sharma, P Adumeau, C Rodriguez, K Fung, BM Zeglis Journal of Nuclear Medicine 60 (8), 1174-1182, 2019 | 40 | 2019 |
| Hybrid fluorescent conjugates of COX-2 inhibitors: Search for a COX-2 isozyme imaging cancer biomarker A Bhardwaj, J Kaur, SK Sharma, Z Huang, F Wuest, EE Knaus Bioorganic & medicinal chemistry letters 23 (1), 163-168, 2013 | 40 | 2013 |
| A Systematic Evaluation of Antibody Modification and 89Zr-Radiolabeling for Optimized Immuno-PET SK Sharma, JM Glaser, KJ Edwards, E Khozeimeh Sarbisheh, AK Salih, ... Bioconjugate chemistry 32 (7), 1177-1191, 2020 | 39 | 2020 |
| Targeting lysyl oxidase for molecular imaging in breast cancer M Wuest, M Kuchar, SK Sharma, S Richter, I Hamann, M Wang, L Vos, ... Breast cancer research 17, 1-15, 2015 | 39 | 2015 |
| The influence of glycans-specific bioconjugation on the FcγRI binding and in vivo performance of 89Zr-DFO-pertuzumab D Vivier, K Fung, C Rodriguez, P Adumeau, GA Ulaner, JS Lewis, ... Theranostics 10 (4), 1746, 2020 | 36 | 2020 |
| Synthesis of three 18 F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold O Tietz, SK Sharma, J Kaur, J Way, A Marshall, M Wuest, F Wuest Organic & Biomolecular Chemistry 11 (46), 8052-8064, 2013 | 34 | 2013 |
| Preclinical optimization of antibody‐based radiopharmaceuticals for cancer imaging and radionuclide therapy—Model, vector, and radionuclide selection LM Carter, S Poty, SK Sharma, JS Lewis Journal of Labelled Compounds and Radiopharmaceuticals 61 (9), 611-635, 2018 | 31 | 2018 |
